{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:34:28Z","timestamp":1768883668155,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clgc.2024.102119","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:23:03Z","timestamp":1715311383000},"page":"102119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0494-7839","authenticated-orcid":false,"given":"Mario","family":"de Angelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-8438","authenticated-orcid":false,"given":"Lukas","family":"Scheipner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Siech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-0519","authenticated-orcid":false,"given":"Letizia Maria Ippolita","family":"Jannello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-2876","authenticated-orcid":false,"given":"Andrea","family":"Baudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-3701","authenticated-orcid":false,"given":"Francesco Di","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2556-9934","authenticated-orcid":false,"given":"Kira","family":"Vitucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Ahyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Carmignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2024.102119_bib0001","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102119_bib0002","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1016\/j.clgc.2021.03.010","article-title":"Radical cystectomy vs. multimodality treatment in t2n0m0 bladder cancer: a population-based, age-matched analysis","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"8","key":"10.1016\/j.clgc.2024.102119_bib0003","doi-asserted-by":"crossref","first-page":"380.e19","DOI":"10.1016\/j.urolonc.2022.03.014","article-title":"Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race\/ethnicity","volume":"40","author":"Sorce","year":"2022","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2024.102119_bib0004","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s00345-022-04183-0","article-title":"Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race\/ethnicity","volume":"40","author":"Sorce","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2024.102119_bib0005","unstructured":"R: The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed June 4, 2023."},{"issue":"4","key":"10.1016\/j.clgc.2024.102119_bib0006","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jval.2013.01.005","article-title":"Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research","volume":"16","author":"Bekelman","year":"2013","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.clgc.2024.102119_bib0007","doi-asserted-by":"crossref","first-page":"272.e1","DOI":"10.1016\/j.urolonc.2021.12.015","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder","volume":"40","author":"Softness","year":"2022","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102119_bib0008","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3857\/roj.2023.00262","article-title":"Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer","volume":"41","author":"Vieira","year":"2023","journal-title":"Radiat Oncol J"},{"issue":"6","key":"10.1016\/j.clgc.2024.102119_bib0009","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2024.102119_bib0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(13)70255-9","volume":"14","author":"Mitin","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102119_bib0011","doi-asserted-by":"crossref","first-page":"93.e1","DOI":"10.1016\/j.clgc.2021.08.003","article-title":"Radical cystectomy vs. radiotherapy in urothelial bladder cancer in elderly and very elderly patients","volume":"20","author":"Horlemann","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102119_bib0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13566-017-0319-2","article-title":"Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation","volume":"6","author":"Korpics","year":"2017","journal-title":"J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102119_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.eururo.2007.12.031","article-title":"Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"54","author":"Herr","year":"2008","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.clgc.2024.102119_bib0014","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clgc.2024.102119_bib0015","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.juro.2018.06.001","article-title":"Effectiveness of transurethral resection plus systemic chemotherapy as definitive treatment for muscle invasive bladder cancer in population level data","volume":"200","author":"Audenet","year":"2018","journal-title":"J Urol"},{"issue":"23","key":"10.1016\/j.clgc.2024.102119_bib0016","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.3390\/cancers14235766","article-title":"Differences in cancer-specific mortality after trimodal therapy for T2N0M0 bladder cancer according to histological subtype","volume":"14","author":"Barletta","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2024.102119_bib0017","doi-asserted-by":"crossref","DOI":"10.1007\/s40615-024-01973-7","article-title":"The effect of race\/ethnicity on cancer-specific mortality after trimodal therapy","author":"de Angelis","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"issue":"12","key":"10.1016\/j.clgc.2024.102119_bib0018","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/cam4.4625","article-title":"Conditional survival of trimodal therapy for nonmetastatic muscle-invasive bladder cancer: a <scp>SEER<\/scp>database analysis","volume":"11","author":"Shangguan","year":"2022","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102119_bib0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urolonc.2020.10.005","article-title":"Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer","volume":"41","author":"Ballas","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102119_bib0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOU.0000000000001113","article-title":"Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer","volume":"33","author":"De Angelis","year":"2023","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2024.102119_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/bju.16333","article-title":"Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer","author":"de Angelis","year":"2024","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2024.102119_bib0022","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur Urol"},{"issue":"33","key":"10.1016\/j.clgc.2024.102119_bib0023","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102119_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.01.014","article-title":"Benefit of neoadjuvant cisplatin-based chemotherapy for invasive bladder cancer patients treated with radiation-based therapy in a real-world setting: an inverse probability treatment weighted analysis","author":"Kool","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102119_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eururo.2016.12.002","article-title":"Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy","volume":"72","author":"Krasnow","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102119_bib0026","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the massachusetts general hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T08:04:25Z","timestamp":1718525065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1558767324000909"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102119","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102119"}}